{
    "pmcid": "11599457",
    "qa_pairs": {
        "What changes in the Spike protein positions were associated with lowered neutralization responses in XBB lineages?": [
            "Positions 452, 455, and 456.",
            "Positions 350, 452, and 500.",
            "Positions 400, 455, and 460.",
            "Positions 452, 460, and 470."
        ],
        "What does the study suggest about the maturation of neutralization breadth over time?": [
            "There was an increase in cross-reactivity across all SARS-CoV-2 variants, countering initial immune imprinting.",
            "Neutralization breadth remained constant, focusing on ancestral lineages.",
            "Cross-reactivity decreased as new variants emerged.",
            "Neutralization breadth was only significant for pre-Omicron lineages."
        ],
        "What is a key strategy for designing nanobody binders according to the study?": [
            "Targeting conserved epitopes across variants to enhance cross-reactivity and efficacy.",
            "Focusing solely on the most recent variant mutations.",
            "Designing binders that only target the ancestral SARS-CoV-2 strain.",
            "Creating nanobodies that exclusively bind to TMPRSS2."
        ],
        "What was the predicted transmission advantage of the JN.1 variant attributed to?": [
            "Changes in viral entry preferences, specifically the preferential utilization of ACE2 pools that cannot engage TMPRSS2 at its Collectrin-Like Domain (CLD).",
            "Increased replication speed within host cells.",
            "Enhanced ability to evade host immune responses.",
            "Mutations in the viral RNA polymerase that increased replication fidelity."
        ],
        "Which variants were ranked among the most evasive alongside JN.1?": [
            "EG.5.1, HV.1, and XCT.",
            "KP.3, EG.5.1, and HV.1.",
            "XBB, EG.5.1, and KP.3.",
            "XCT, HV.1, and KP.3."
        ]
    }
}